Perspectives on Health Care

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Practice Co-Leader Lowell Brown and Counsel Sarah Benator will offer legal perspectives on pandemic-related issues facing hospital leaders at The Institute for Medical Leadership’s 2021 Chief of Staff Boot Camp in February.

Recent updates to the federal Anti-Kickback Statute give providers additional flexibility to enter into innovative arrangements, but before doing so, providers must ensure they understand the safe harbor requirements necessary to protect those arrangements.

This is the latest in a series of articles discussing selected updates to the Department of Consumer Affairs’ (DCA) waivers issued in response to Governor Newsom’s March 30, 2020 Executive Order N-39-20.

Headlines that Matter for Companies and Executives in Regulated Industries

Headlines that Matter for Companies and Executives in Regulated Industries

Schiff Hardin LLP is pleased to announce that 28 attorneys have been recognized on the 2021 Illinois Super Lawyers and Rising Stars lists.

Headlines that Matter for Companies and Executives in Regulated Industries

Fraud and abuse regulations have been adapted to meet today’s technology for electronic data, promoting cooperation among health care providers for the exchange of health information and the protection of such information from cyberattacks.

On Wednesday, January 13th, the Healthcare Group Purchasing Industry Initiative (HGPII) released its 15th Annual Report. 

As part of its recent rulemaking process, the Centers for Medicare and Medicaid Services (CMS) finalized a new exception to the Physician Self-Referral Law (the Stark Law) to protect arrangements where limited remuneration is provided to a physician in exchange for items or services provided by the

Black women are three to four times more likely to die from pregnancy-related causes than white women. Most of these deaths are preventable.

Headlines that Matter for Companies and Executives in Regulated Industries

In its first significant Stark Law rulemaking since 2015, the Centers for Medicare and Medicaid Services (CMS) recently issued a new final rule (Final Rule) intending to provide physicians and designated health services (DHS) entities with additional flexibility in complying with the law’s stringent

Headlines that Matter for Companies and Executives in Regulated Industries

In its recent Final Rule significantly revising the federal Physician Self-Referral Law (Stark Law), the Centers for Medicare and Medicaid Services (CMS) implements several important changes to the special rules on compensation set forth in 42 C.F.R. § 411.354(d). 

Enrolling in such a CMS-sponsored innovation model now has an added benefit: a new Anti-Kickback Statute (AKS) safe harbor.

The Healthcare Group Purchasing Organization sector has played a critical role in assisting health systems respond to supply disruptions during the pandemic.

Headlines that Matter for Companies and Executives in Regulated Industries

The Centers for Medicare & Medicaid Services (CMS) published a Final Rule in the Federal Register on December 2, 2020, overhauling the regulations governing the federal Physician Self-Referral Law (Stark Law).

The Final Rule of the Stark Law revises the definitions of Fair Market Value and includes a definition of General Market Value to better align with actual practices without unduly restricting innovative relationships between physicians and entities providing designated health services.

On December 28, 2020, Judge Vince Chhabria of the US District Court for the Northern District of California joined Judge Catherine Blake of the US District Court of the District of Maryland in enjoining the application of the Medicare Part B Most Favored Nations Reimbursement Rule.

On December 23, 2020, Judge Catherine Blake of the US District Court for the District of Maryland put in place a 14-day restraining order while she considers whether to issue a preliminary injunction. She plans to consider whether the Centers for Medicare & Medicaid Services rulemaking was adequate

States seeking to regulate pharmacy benefit managers (PBMs) and prescription drug pricing received a win from the Supreme Court, which reversed an Eighth Circuit decision that had invalidated an Arkansas law governing pharmacy and PBM conduct on ERISA preemption grounds.

Headlines that Matter for Companies and Executives in Regulated Industries